Literature: Osimertinib purchased from MedChemExpress. Usage Cited in: J Exp Clin Cancer Res. 2019 May 23;38(1):219. [Abstract]
Customer Validation: U87 and U251 cells are treated with AZD9291 (Osimertinib) or CP-358774 for 4, 24 and 48 h. The expression level of p-ERK are assessed using Western blot analysis.
Homoeriodictyol is an orally active, blood-brain barrier-permeable bitter-masking flavanone that enhances synapse-related protein expression via NCOA4-mediated ferritinophagy (autophagy), ameliorates memory impairment in mice by inhibiting the NLRP3 inflammasome, protects human endothelial cells from oxidative damage by activating Nrf2 and inhibiting mitochondrial dysfunction, exhibits anticancer effects by enhancing ROS activity to induce apoptosis (apoptosis), inhibits the survival and migration of androgen-resistant prostate cancer cells in vitro, and exerts antinociceptive activity in mice.
Activated the nuclear translocation of Nrf2 protein.
Western Blot Analysis
Cell Line:
EA.hy926 cells
Concentration:
1, 2, 5 μM
Incubation Time:
2, 4, 6, 8, 12, 16 h
Result:
Activated the nuclear translocation of Nrf2 protein.
Increased protein levels of Nrf2, NQO1, and γGCS, continued to increase Nrf2 protein levels over the 24 hours tested.
RT-PCR
Cell Line:
EA.hy926 cells
Concentration:
1, 2, 5 μM
Incubation Time:
24 h
Result:
Did not affect mRNA level of Nrf2, but upregulated the levels of NQO1 and GCLM.
Immunofluorescence
Cell Line:
H2O2-induced EA.hy926 cells
Concentration:
2, 5 μM
Incubation Time:
12 h
Result:
Reduce MMP levels.
Reduced cytochrome C protein levels in the cytoplasm and mitochondria.
Inhibited tAIF production and blocks AIF translocation from mitochondria to the nucleus.
Western Blot Analysis
Cell Line:
H2O2-induced EA.hy926 cells
Concentration:
1, 2, 5 μM
Incubation Time:
12 h
Result:
Reduced cytochrome C protein levels in the cytoplasm and mitochondria.
Inhibited tAIF production and blocks AIF translocation from mitochondria to the nucleus.
Inhibited H2O2-induced activations of cleaved caspases -3, -9 and PARP.
Immunofluorescence
Cell Line:
MCF-7, HeLa, and HT-29 cells
Concentration:
500 μg/mL
Incubation Time:
24 h
Result:
Increased the green fluorescence of DCF, increased the fluorescence of Rh123 fluorescence.
Cell Cycle Analysis
Cell Line:
MCF-7, HeLa, and HT-29 cells
Concentration:
500 μg/mL
Incubation Time:
24 h
Result:
Increased the subG1 peaks.
RT-PCR
Cell Line:
MCF-7, HeLa, and HT-29 cells
Concentration:
100 μg/mL
Incubation Time:
24 h
Result:
Increased the expressions of p53, caspase 3, caspase 9, bax, and SOD1 genes.
Aβ25-35-induced AD kunming mice (Male, 7 weeks old) model
Dosage:
10 mg/kg/d
Administration:
p.o., 4 weeks
Result:
Improved memory impairment and cognitive dysfunction, alleviated hippocampal neuronal damage.
Decreased the levels of Aβ1-40, Aβ1-42, and p-Tau in the hippocampus.
Reduced oxidative stress in the brain, reduced the levels of ROS, apoptosis and MDA, increased the levels of GSH-Px and SOD.
Resulted in increased numbers of NK cells, Th cells, Tc cells, and DCs, and decreased numbers of MDSCs and Treg cells in peripheral blood and splenic tissues.
Had excellent anti-inflammatory effects, reduced the protein expression levels of NLRP3, Caspase-1, and ASC, and the inflammatory factors IL-18 and IL-1β in brain tissue.
Animal Model:
Swiss albino mice (adult male, 24-28 g) model
Dosage:
50, 100, 150, and 200 μg/kg
Administration:
i.p., once
Result:
Lowered the writhing responses to acetic acid, showed a dose-responsive relation analgesic effect.
Increased the time respond to thermal pain on a hot plate.
Decreased the licking times in both the early and late phases after formalin injection, alleviated pain in the formalin test.
Lessened licking time after Capsaicin (MS-R45786) injection, indicating a dose-responsive effect.
Reduced paw licking times, mitigated glutamate-induced pain responses.